Trademark Overview
On Monday, May 18, 2026, a trademark application was filed for ESVIAMLI with the United States Patent and Trademark Office. The USPTO has given the ESVIAMLI trademark a serial number of 99829133. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 18, 2026. This trademark is owned by Kymab Limited. The ESVIAMLI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of respiratory, inflammatory, and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease (COPD); Pharmaceutical preparations for the treatment and prevention of atopic dermatitis